Serotonin

Serotonin has been simultaneously oversimplified and underestimated by popular neuroscience. The narrative that it is “the happiness chemical” — deficient in depression, restored by SSRIs — collapses under the weight of the actual pharmacology. Serotonin operates through at least 14 distinct receptor subtypes (5-HT1A through 5-HT7, with additional subtypes), each with different distributions, different downstream signaling cascades, and different — sometimes opposing — functional effects. Activating 5-HT1A receptors in the raphe nuclei reduces serotonin release. Activating 5-HT2A receptors in the cortex can produce anxiety. Activating 5-HT3 receptors in the gut influences nausea and visceral sensation. The notion that more serotonin equals better mood ignores that the system’s complexity is the point. Serotonin does not produce happiness. It modulates the gain on nearly every neural system it contacts: emotional reactivity, impulse control, pain perception, appetite, sleep architecture, social behavior, and cognitive flexibility. Its function is regulatory, not hedonic.

Moncrieff and colleagues’ 2022 umbrella review at University College London assessed the entire body of evidence for the serotonin hypothesis of depression and found no consistent support for the claim that depression is caused by lowered serotonin activity. This did not mean serotonin is irrelevant to mood — it meant the simple deficiency model was wrong. Cools and colleagues at the Donders Institute demonstrated that serotonin’s role in behavior is better understood as a modulator of aversive processing: it regulates the brain’s sensitivity to punishment, loss, and social threat rather than generating positive affect directly. Yano and colleagues at Caltech revealed that approximately 90% of the body’s serotonin is produced by enterochromaffin cells in the gut, and that gut microbiome composition directly influences serotonin synthesis — establishing a concrete mechanism for the gut-brain axis effects that clinical observation had long noted but could not explain. Muller and Bhatt Jacobs’ research further mapped how serotonin interacts with the HPA stress axis, showing that chronic stress depletes tryptophan — serotonin’s precursor — through inflammatory activation of the kynurenine pathway, shunting the raw material away from serotonin production and toward neurotoxic metabolites.

The clinical implications of serotonin’s actual complexity are profound and largely unaddressed by standard care. Prescribing an SSRI increases serotonin availability globally across all 14 receptor subtypes, across every brain region and the gut — a pharmacological approach roughly equivalent to adjusting every dial on a mixing board simultaneously because one channel is too quiet. Some individuals respond well because the global increase happens to correct the specific imbalance driving their symptoms. Others experience paradoxical worsening, emotional blunting, sexual dysfunction, or gastrointestinal distress because the intervention is indiscriminate. The question is never simply “does this person need more serotonin?” It is “which serotonergic circuits are dysregulated, at which receptor subtypes, under which conditions?”

Dr. Sydney Ceruto’s approach at MindLAB Neuroscience recognizes serotonin as one component within a complex neuromodulatory ecology — not an isolated target to be increased or decreased. Through Real-Time Neuroplasticity™, she works with the behavioral and emotional patterns that emerge from serotonergic system dysregulation: the impulsivity, the mood instability, the sleep disruption, the heightened sensitivity to social rejection, the cognitive rigidity. These patterns are accessible to intervention during the moments they manifest, when the relevant circuits are active and the serotonergic modulation shaping behavior can be influenced through precisely timed experience rather than global pharmacological adjustment. A strategy call maps how serotonergic function presents in your specific patterns — not as a lab value but as lived experience that neuroscience can decode. The articles below explore the neuroscience of serotonin, mood regulation, the gut-brain connection, and the mechanisms that determine whether this critical neurotransmitter system serves stability or generates volatility.